344 related articles for article (PubMed ID: 31833531)
21. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
[TBL] [Abstract][Full Text] [Related]
23. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
[TBL] [Abstract][Full Text] [Related]
24. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
25. Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinoma.
Casula L; Elena Giacomazzo G; Conti L; Fornasier M; Manca B; Schlich M; Sinico C; Rheinberger T; Wurm FR; Giorgi C; Murgia S
J Colloid Interface Sci; 2024 Sep; 670():234-245. PubMed ID: 38761576
[TBL] [Abstract][Full Text] [Related]
26. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
27. Luminescent naphthalimide-tagged ruthenium(ii)-arene complexes: cellular imaging, photocytotoxicity and transferrin binding.
Srivastava P; Verma M; Kumar A; Srivastava P; Mishra R; Sivakumar S; Patra AK
Dalton Trans; 2021 Mar; 50(10):3629-3640. PubMed ID: 33625414
[TBL] [Abstract][Full Text] [Related]
28. Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.
Roque JA; Barrett PC; Cole HD; Lifshits LM; Bradner E; Shi G; von Dohlen D; Kim S; Russo N; Deep G; Cameron CG; Alberto ME; McFarland SA
Inorg Chem; 2020 Nov; 59(22):16341-16360. PubMed ID: 33126792
[TBL] [Abstract][Full Text] [Related]
29. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
Fayad C; Audi H; Khnayzer RS; Daher CF
J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
[TBL] [Abstract][Full Text] [Related]
30. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
31. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
32. A photoactivatable Ru (II) complex bearing 2,9-diphenyl-1,10-phenanthroline: A potent chemotherapeutic drug inducing apoptosis in triple negative human breast adenocarcinoma cells.
Mansour N; Bodman-Smith K; Khnayzer RS; Daher CF
Chem Biol Interact; 2021 Feb; 336():109317. PubMed ID: 33197429
[TBL] [Abstract][Full Text] [Related]
33. Near-IR/Visible-Emitting Thiophenyl-Based Ru(II) Complexes: Efficient Photodynamic Therapy, Cellular Uptake, and DNA Binding.
Zhang SQ; Meng TT; Li J; Hong F; Liu J; Wang Y; Gao LH; Zhao H; Wang KZ
Inorg Chem; 2019 Oct; 58(20):14244-14259. PubMed ID: 31595752
[TBL] [Abstract][Full Text] [Related]
34. NIR-Absorbing Ru
Lifshits LM; Roque JA; Cole HD; Thummel RP; Cameron CG; McFarland SA
Chembiochem; 2020 Dec; 21(24):3594-3607. PubMed ID: 32761725
[TBL] [Abstract][Full Text] [Related]
35. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
36. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, spectral studies, DNA binding, photocleavage, antimicrobial and anticancer activities of isoindol Ru(II) polypyridyl complexes.
Ravi C; Vuradi RK; Avudoddi S; Yata PK; Putta VR; Srinivas G; Merugu R; Satyanarayana S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):788-806. PubMed ID: 31081456
[TBL] [Abstract][Full Text] [Related]
38. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
[TBL] [Abstract][Full Text] [Related]
39. A long-lived cuprous bis-phenanthroline complex for the photodynamic therapy of cancer.
Al Hageh C; Al Assaad M; El Masri Z; Samaan N; El-Sibai M; Khalil C; Khnayzer RS
Dalton Trans; 2018 Apr; 47(14):4959-4967. PubMed ID: 29557474
[TBL] [Abstract][Full Text] [Related]
40. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
